Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia
暂无分享,去创建一个
[1] W. Elliott. Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2009 .
[2] F. Messerli,et al. Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. , 2008, Kidney international.
[3] Alan C. Wilson,et al. Long-Term Fatal Outcomes in Subjects With Stroke or Transient Ischemic Attack: Fourteen-Year Follow-Up of the Systolic Hypertension in the Elderly Program , 2008, Stroke.
[4] E. Jaimes,et al. Thiazide diuretics, endothelial function, and vascular oxidative stress , 2008, Journal of hypertension.
[5] B. Davis,et al. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2008, Archives of internal medicine.
[6] Barry J. Davis,et al. Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension , 2007, Diabetes Care.
[7] R. Fogari,et al. Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients. , 2008, Internal medicine.
[8] B. Rovin,et al. Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. , 2007, Kidney international.
[9] B. Croker,et al. Thiazide-induced subtle renal injury not observed in states of equivalent hypokalemia. , 2007, Kidney international.
[10] T. Srinivas,et al. Thiazide diuretics exacerbate fructose-induced metabolic syndrome. , 2007, Journal of the American Society of Nephrology : JASN.
[11] G. Gamba,et al. Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. , 2007, Journal of the American Society of Nephrology.
[12] V. Campese. Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] R. Grimm. Diuretics are preferred over angiotensin II-converting enzyme inhibitors for initial therapy of uncomplicated hypertension. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[14] B. Rovin,et al. The design of ALLHAT may have biased the study's outcome in favor of the diuretic cohort , 2007, Nature Clinical Practice Nephrology.
[15] C. Luley,et al. Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels , 2007, Vascular health and risk management.
[16] Semenkin Aa. Possibilities of using indices of vascular wall function as markers of negative metabolic effects of treatment with thiazide diuretics in patients with essential hypertension , 2007 .
[17] A. Semenkin. [Possibilities of using indices of vascular wall function as markers of negative metabolic effects of treatment with thiazide diuretics in patients with essential hypertension]. , 2007, Terapevticheskii arkhiv.
[18] I. Reid,et al. The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women , 2007, Osteoporosis International.
[19] M. García-Ruiz,et al. Extracorporeal renal lithotripsy: evolution of residual lithiasis treated with thiazides. , 2006, Urology.
[20] B. Davis,et al. Abstract 2734: Heart Failure with Preserved and Impaired Left Ventricular Systolic Function in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) , 2006 .
[21] G. Bakris,et al. Thiazide Diuretics, Potassium, and the Development of Diabetes: A Quantitative Review , 2006, Hypertension.
[22] T. Kaşifoğlu,et al. The effects of thiazide and thiazide-potassium sparing diuretics on fibrinolytic system parameters. , 2006, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology.
[23] R. Hawkins. Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the united states? , 2006, Current hypertension reports.
[24] L. Ghiadoni,et al. Thiazide diuretics in the treatment of hypertension: an update. , 2006, Journal of the American Society of Nephrology : JASN.
[25] Takahiko Nakagawa,et al. A causal role for uric acid in fructose-induced metabolic syndrome. , 2006, American journal of physiology. Renal physiology.
[26] D. Sica. Chlorthalidone: has it always been the best thiazide-type diuretic? , 2006, HYPERTENSION.
[27] G. Bergus,et al. Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure , 2006, Hypertension.
[28] A. Nazarov,et al. [Comparative assessment of hypotensive, metabolic, and endothelial effects of indapamide-retard and hydrochlorothiazide in patients with essential hypertension]. , 2006, Kardiologiia.
[29] K. Leung,et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] T. Nakagawa,et al. Uric Acid – A Uremic Toxin? , 2005, Blood Purification.
[31] G. Bakris,et al. Are Chlorthalidone and Hydrochlorothiazide Equivalent Blood‐Pressure‐Lowering Medications? , 2005, Journal of clinical hypertension.
[32] M. Houston,et al. Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis. , 2005, American journal of hypertension.
[33] E. Block,et al. Hyperuricemia induces endothelial dysfunction. , 2005, Kidney international.
[34] B. Davis,et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2005, Archives of internal medicine.
[35] A. Morganti. Should a diuretic always be the first choice in patients with essential hypertension? The case for no. , 2005, Journal of the American Society of Nephrology : JASN.
[36] Daoyan Liu,et al. Thiazide-Like Diuretics Attenuate Agonist-Induced Vasoconstriction by Calcium Desensitization Linked to Rho Kinase , 2005, Hypertension.
[37] T. Nakagawa,et al. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. , 2005, Seminars in nephrology.
[38] W. Willett,et al. A prospective study of thiazide use and fractures in women , 2005, Osteoporosis International.
[39] A. Hughes,et al. How do thiazide and thiazide-like diuretics lower blood pressure? , 2004, Journal of the renin-angiotensin-aldosterone system : JRAAS.
[40] W. Elliott,et al. Chlorthalidone vs other low-dose diuretics. , 2004, JAMA.
[41] Taku Inoue,et al. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[42] G. Reboldi,et al. Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects , 2004, Hypertension.
[43] R. Fogari,et al. Effect of delapril–manidipine combination vs irbesartan–hydrochlorothiazide combination on fibrinolytic function in hypertensive patients with type II diabetes mellitus , 2004, Journal of Human Hypertension.
[44] M. Houston. ALLHAT debate: diuretics are not preferred, first-line initial therapy for hypertension. , 2004, Archives of internal medicine.
[45] Daniel W. Jones,et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.
[46] M. Izar,et al. Hydrochlorothiazide abolishes the anti‐atherosclerotic effect of quinapril , 2003, Clinical and experimental pharmacology & physiology.
[47] A. Hofman,et al. Thiazide Diuretics and the Risk for Hip Fracture , 2003, Annals of Internal Medicine.
[48] L. Lindholm,et al. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study) , 2003, Journal of hypertension.
[49] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[50] C. Luley,et al. Antihypertensive treatment and homocysteine concentrations. , 2003, Metabolism: clinical and experimental.
[51] R. Schmieder,et al. Effect of AT1 receptor blockade on endothelial function in essential hypertension. , 2003, American journal of hypertension.
[52] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[53] L. Truong,et al. A role for uric acid in the progression of renal disease. , 2002, Journal of the American Society of Nephrology : JASN.
[54] D. Vaughan,et al. ACE Inhibition Versus Angiotensin Type 1 Receptor Antagonism: Differential Effects on PAI-1 Over Time , 2002, Hypertension.
[55] T. Nakagawa,et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. , 2002, American journal of physiology. Renal physiology.
[56] A. J. Reyes. Diuretics in the therapy of hypertension , 2002, Journal of Human Hypertension.
[57] Eric Boerwinkle,et al. Predictors of antihypertensive response to a standard dose of hydrochlorothiazide for essential hypertension. , 2002, Kidney international.
[58] M. Alderman,et al. High and low serum potassium associated with cardiovascular events in diuretic-treated patients , 2001, Journal of hypertension.
[59] J. Staessen,et al. Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension , 2001, Journal of hypertension.
[60] M. Pahor,et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP) , 2000, Journal of hypertension.
[61] Giuseppe Mancia,et al. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.
[62] H. Vetter,et al. Fibrinolytic function in diuretic-induced volume depletion. , 2000, American journal of hypertension.
[63] M. Alderman,et al. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. , 1999, Hypertension.
[64] M. Baican,et al. Vasodilatory effect of diuretics is dependent on inhibition of vascular smooth muscle carbonic anhydrase by a direct mechanism of action. , 1999, Drugs under experimental and clinical research.
[65] R. Zulli,et al. Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension. , 1999, Hypertension.
[66] G. D. Johnston,et al. A randomized comparison of a conventional dose, a low dose and alternate‐day dosing of bendrofluazide in hypertensive patients , 1998, Journal of hypertension.
[67] J. Mehta,et al. Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet. , 1998, American journal of physiology. Heart and circulatory physiology.
[68] B. Davis,et al. Influence of Long-term, Low-Dose, Diuretic-Based, Antihypertensive Therapy on Glucose, Lipid, Uric Acid, and Potassium Levels in Older Men and Women With Isolated Systolic Hypertension The Systolic Hypertension in the Elderly Program , 1998 .
[69] A. Marette,et al. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent. , 1998, American journal of physiology. Endocrinology and metabolism.
[70] J. Mehta,et al. Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet. , 1998, The American journal of physiology.
[71] B. Psaty,et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.
[72] M. Le Hir,et al. Thiazide treatment of rats provokes apoptosis in distal tubule cells. , 1996, Kidney international.
[73] A. Hoes. Non‐potassium‐sparing diuretics and risk of sudden cardiac death , 1995, Journal of hypertension.
[74] T. Raghunathan,et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. , 1994, The New England journal of medicine.
[75] V. Cairns,et al. Short report: Ramipril and hydrochlorothiazide combination therapy in hypertension: a clinical trial of factorial design , 1993, Journal of hypertension.
[76] Chen Tm,et al. Large differences in the biological half-life and volume of distribution of hydrochlorothiazide in normal subjects from eleven studies. Correlation with their last blood sampling times. , 1992 .
[77] W. L. Chiou,et al. Large differences in the biological half-life and volume of distribution of hydrochlorothiazide in normal subjects from eleven studies. Correlation with their last blood sampling times. , 1992, International journal of clinical pharmacology, therapy, and toxicology.
[78] C. Bulpitt,et al. Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly. , 1991, Journal of hypertension.
[79] K. Jamerson,et al. Metabolic adverse effects of thiazide diuretics: the importance of normokalaemia. , 1991, Journal of internal medicine. Supplement.
[81] L. Wilkins. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial. , 1990, Circulation.
[82] M. Brodie,et al. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. , 1990, BMJ.
[83] D. Reda,et al. Volume (Weight) Loss and Blood Pressure Response Following Thiazide Diuretics , 1988, Hypertension.
[84] C. Bulpitt,et al. Glucose intolerance during diuretic therapy in elderly hypertensive patients. A second report from the European Working Party on high blood pressure in the elderly (EWPHE). , 1986, Postgraduate medical journal.
[85] P. Raskin,et al. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. , 1985, The New England journal of medicine.
[86] G. Norbiato,et al. Effects of potassium supplementation on insulin binding and insulin action in human obesity: protein‐modified fast and refeeding , 1984, European journal of clinical investigation.
[87] D. Andersen,et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. , 1983, Diabetes.
[88] M I Rubin,et al. Systemic hypertension. , 1964, Pediatric clinics of North America.
[89] W. Hollander,et al. Chlorothiazide: a new type of drug for the treatment of arterial hypertension. , 1957, BMQ; the Boston medical quarterly.